IX Acquisition Corp
IX Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on companies in the technology, media and telecommunications, and information and communication technology industries. The company was incorporated in 2021 and i… Read more
IX Acquisition Corp (IXAQ) - Total Liabilities
Latest total liabilities as of March 2025: $13.70 Million USD
Based on the latest financial reports, IX Acquisition Corp (IXAQ) has total liabilities worth $13.70 Million USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
IX Acquisition Corp - Total Liabilities Trend (2021–2024)
This chart illustrates how IX Acquisition Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
IX Acquisition Corp Competitors by Total Liabilities
The table below lists competitors of IX Acquisition Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SVB & T Corp
OTCQX:SVBT
|
USA | $564.49 Million |
|
Jagsonpal Pharmaceuticals Limited
NSE:JAGSNPHARM
|
India | ₹461.88 Million |
|
CHA Vaccine Institute Co. Ltd.
KQ:261780
|
Korea | ₩22.26 Billion |
|
Phunware Inc
NASDAQ:PHUN
|
USA | $7.32 Million |
|
Tobii AB (publ)
F:24T
|
Germany | €900.00 Million |
|
Tristar Gold
OTCQB:TSGZF
|
USA | $2.60 Million |
|
Jaanh CosmeticsInc.
KQ:219550
|
Korea | ₩17.22 Billion |
|
Prostemics Co. Ltd
KQ:203690
|
Korea | ₩33.62 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down IX Acquisition Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IX Acquisition Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IX Acquisition Corp (2021–2024)
The table below shows the annual total liabilities of IX Acquisition Corp from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $13.65 Million | +42.64% |
| 2023-12-31 | $9.57 Million | -29.09% |
| 2022-12-31 | $13.50 Million | -33.80% |
| 2021-12-31 | $20.39 Million | -- |